Direct-to-employer health insurance plans, in which an employer contracts directly with a health care network for coverage, restrict provider choice but are generally less expensive for employers and employees.
The school’s primary classroom and education facility is being moved from its longtime home on the Indianapolis campus to be closer to the new IU Health teaching hospital, set to open in 2027.
Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a first-of-its-kind blood test to diagnose Alzheimer’s disease.
Questions included whether the Indianapolis-based drugmaker is working to improve insurance coverage for the drug and highlighted users’ concerns about comparisons with Novo Nordisk’s Wegovy.
Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months.
Boston-based Verve Therapeutics is a Nasdaq-traded company focused on genetic medicines for cardiovascular disease.
Syndeio Biosciences sees burgeoning potential to treat mental health and cognitive conditions, including Alzheimer’s and depression, with therapies that target the almost countless minuscule brain synapses that give people the ability to think and function.
The five-story, 150,000 square-foot building will be built next to the Herron School of Art and Design’s Eskenazi Fine Arts Center on Indiana Avenue in Indianapolis.
The Franciscan Healthy Living Center, which opened in 2020, is designed to help those who’ve been through cancer, heart disease, surgery or other serious conditions improve their health factors, including diet, fitness, sleep and mental health.
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other conditions because it comes in pill form, not an injection.
Lilly in February announced plans to add four U.S. manufacturing sites at yet-to-be-determined sites as part of a roughly $27 billion investment.
The med-tech company sources its products from a Chinese manufacturer that is one of very few in the world capable of producing cellular-connected medical devices.
On Thursday, pharmacies were supposed to stop making the copies of the medications that had become popular during shortages of the brand-name drugs.
IU Health’s People Mover is unusual—or it certainly was at the time it was conceived—because of its use of public right of way.
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
The extended partnership holds the potential to be the largest industry-academic agreement of its kind in the United States, Purdue President Mung Chiang said.
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
